Following through with a promise delivered on StockTwits last week, “The Vega Group” has published a negative report on GW Pharma (NASDAQ: GWPH) (LON: GWP). The stock had reacted negatively on Thursday when “SyntecVentures” tweeted out its pending release.
The Vega Group is a “subsidiary of Syntec Ventures”, but there is little information available publicly about either entity, and the report itself was posted to a Google drive. The report, which mistakenly references “GPW” several times, suggests that the fair valuation would be, at best, $52.93 and possibly just $36.28. GWPH stock closed Thursday at $81.63 and is currently near $78, with a low of $77 so far.
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.